Scientists test drug mix in healthy volunteers
NCT ID NCT05248945
Summary
This study aimed to understand how taking carbamazepine (an existing medication) affects how the body processes a single dose of a new drug called evobrutinib. It involved 14 healthy participants who stayed in a research unit for observation. The main goal was to measure drug levels in the blood to see if carbamazepine changes how evobrutinib works in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvisan GmbH
Neu-Ulm, Bavaria, Germany
Conditions
Explore the condition pages connected to this study.